August 30, 2008

Online CME Programs in Venous and Cardiovascular Thrombosis

• St-Elevation Myocardial Infarction: The Landmark HORIZONS AMI Trial, Investigation, Illumination, and Implications for Management and Mortality in Patients with High Risk ACS – Program Faculty: Gregg W. Stone, MD, FACC [Webcast] - NEW!!!This program is designed for all practitioners with the following specialties or subspecialties: cardiologists, interventional cardiologists, emergency physicians, hospitalists and hospital pharmacists. The University of Massachusetts Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM.

• STEMI and High Risk ACS: Emergency Department and Interventional Cardiology Therapeutic Teams (EDICT) for Acute Coronary Syndromes – Program Faculty: Sunil V. Rao, MD, FACC, Frederick Feit, MD, FACC, Harold L. Dauerman, MD, Gregg W. Stone, MD [Webcast] - NEW!!!This symposium has been conceived for cardiologists, non-invasive specialists; prevention-oriented cardiologists; cardiologists, invasive specialists; emergency medicine specialists; coronary care unit (CCU) specialists and directors; specialists in invasive vascular management; program directors, cardiovascular medicine and emergency medicine; fellows in cardiovascular medicine and emergency medicine; clinical pharmacists and pharmacologists; pharmacy directors (cardiovascular medicine); investigators and clinical trial specialists; invasive cardiology. The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s).

• Acute Coronary Syndrome: The Emergence of Consistent and Unified Management Strategies for STEMI and NSTEMI – Program Faculty: Sunil V. Rao, MD, FACC, Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FAHA , Harold L. Dauerman, MD , Gregg W. Stone, MD, Ron Waksman, MD, FACC [Webcast] - NEW!!!This program is designed for all practitioners with the following specialties or subspecialties: cardiologists; interventional cardiologists; emergency physicians; hospitalists and hospital pharmacists. The University of Massachusetts Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM.

• Antithrombosis Therapy Management: Module 1 Traditional Oral Anticoagulants [Online]This module will cover the pharmacology, therapeutics, and drug interactions of oral anticoagulant therapy. After reviewing this module the participant will be familiar with proper indications for oral anticoagulation, goal of treatment, length of treatment, patient monitoring issues, and potential interactions with warfarin therapy. Objectives: Discuss proper indications, duration and intensity for oral anticoagulation therapy; List proper monitoring parameters for patients receiving warfarin therapy; Identify key educational elements for patients on warfarin therapy; Recommend proper warfarin dosing and frequency of patient follow up; List side effects associated with oral anticoagulants; Identify drug-drug, drug-diet, drug-disease state interactions with warfarin. The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of the evaluation form and a passing grade of 70% or better on the self-assessment questions are pre-requisites for receiving continuing education credit. A statement of credit verifying 0.5 CEUs (5 contact hours) will be available to the participant the completion of the pre-requisites.

• Venous Thrombosis – Program Faculty: Kenneth A. Bauer, MD, David Feinbloom, MD [Webcast]The most common presentations of venous thromboembolism (VTE) are deep vein thrombosis (DVT) of the lower extremity and pulmonary embolism. A risk factor for VTE, either hereditary or acquired, can now be identified in approximately 80 percent of patients. Furthermore, there is often more than one factor at play in a given patient. As an example, 50 percent of thrombotic events in patients with inherited thrombophilia are associated with an acquired risk factor (eg, surgery, pregnancy, oral contraceptives). In addition, some patients have more than one form of inherited thrombophilia and appear to be at greater risk for thrombosis. The approach to the adult patient with deep venous thrombosis will be discussed here with an emphasis upon the use of diagnostic tests to establish an accurate diagnosis and the initiation of anticoagulant therapy. Indications for testing for an inherited cause of thrombophilia are addressed along with the potential implications of the discovery of an underlying thrombophilic defect for the patient and affected relatives. Harvard Medical School designates this educational activity for a maximum of 1 category 1 credits toward the AMA Physician's Recognition Award™.

• Prevention and Management of Venous Thromboembolism–From Landmark Evidence to Optimal Clinical Practice; Program Chairman: Samuel Z. Goldhaber, MD [Webcast]The educational activity is designed for physicians likely to encounter patients at risk for VTE, among them: primary care physicians, hospitalist physicians, critical care specialists/intensivists, orthopedic surgeons, general surgeons, hematologists, pulmonologists, thrombosis medicine anticoagulation specialists, hospital-focused internists, surgical oncologists, and emergency medicine specialists. The UMMS designates this continuing medical education activity for up to 3 credit hours in Category 1 toward the Physicians Recognition Award of the American Medical Association.

• Critical Challenges and Landmark Advances in Vascular Interventional Management: 2007 AHA/ACC Guidelines for NSTEMI: Implications for DTIs, Switching Anticoagulants, and Bleeding Reduction Across the ACS Spectrum—Program Faculty: Deepak L. Bhatt, MD, FACC, Steven V. Manoukian, MD, Gregg W. Stone, MD, FACC, Ron Waksman, MD, FACC [Webcast]This symposium is designed for, cardiologists, non-invasive specialists, cardiologists, invasive specialists, coronary care unit (CCU) specialists and directors, specialists in invasive vascular management, program directors, cardiovascular medicine, fellows in cardiovascular medicine, clinical pharmacists and pharmacologists, pharmacy directors (cardiovascular medicine), investigators and clinical trial specialists, invasive cardiology, cardiac catheterization healthcare personnel, interventional radiologists (vascular medicine), emergency medicine specialists, cardiovascular nurses. The University of Massachusetts Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM.

• Critical Challenges in Orthopedic Surgery: A Science-to-Strategy CME Clinical Excellence Summit Focused on DVT Prophylaxis in High Risk Patients; Javid Parvizi, MD, FRCS [Webcast] This webcast is designed for all practitioners with the following specialties or subspecialties: Orthopedic and other surgeons, orthopedic anesthesiologists, and other healthcare providers who manage patients undergoing orthopedic procedures. The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)TM.

• Hypertension in African Americans: Linking Scientific Advances, Mechanism of Action, and Landmark Trials to Cardiovascular Protection (Focus on Cardioselective Beta-Blockers)—Program Faculty: Kenneth A. Jamerson, MD [Webcast]This program is designed for all practitioners with the following specialties or subspecialties: Primary Care, Cardiologists, Hypertension Specialists, Internists with Cardiology Specialty Focus, Preventive Medicine Specialists, and Endocrinologists. The University of Massachusetts Medical School designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM.

• Heart Disease and Stroke: Applying Evidence to the Front Lines of Practice: Focus on Lipid-Lowering Agents Across the Cardiovascular Disease and Stroke Risk Spectrum; Program Chairman: Paul M. Ridker, MD [Webcast]This symposium is designed for Primary Care Physicians, Cardiologists, Hypertension Specialists Internists with Cardiology Specialty Focus, Preventive Medicine Specialists Endocrinologists, Diabetologists, Nurse Practitioners Geriatricians Endocrinologists, Pharmacists, Physician Assistants. The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)TM.

• Advancing The Management of Acute Coronary Syndromes (ACS)–The Emergency Medicine Perspective; Program Chairman: Charles V. Pollack, MA, MD, FACEP, FAAEM [Webcast]This symposium is designed for emergency medicine specialists, program directors, cardiologists, emergency medicine nurses, PAs, NPs, prehospital care providers, pharmacists, and other healthcare providers caring for patients with acute cardiovascular disease. The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)TM.

• Optimizing Net Clinical Benefit in PCI: Applying Late-Breaking, Research in ACS Management to the Cardiac Catheterization Laboratory; Program Chairman: Jeffrey J. Popma, MD, FSCAI [Webcast]This program is intended for interventional cardiologists, as well as physician specialists who manage patients in the emergency department, coronary care unit, and cardiac catheterization laboratory. The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)TM.

• ACS Management in the Emergency Department: Approaches to Risk Assessment and Antithrombotic Therapy; Program Chairman: Charles V. Pollack, MA, MD, FACEP, FAAEM [Webcast]This program is intended for emergency physicians, as well as physician specialists who manage patients in the coronary care unit, and cardiac catheterization laboratory. The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)TM.

• Interventional Cardiology Update: Redefining Efficacy for PCI and Management of Acute Coronary Syndromes—From Initial Presentation to the Cardiac Catheterization Laboratory; Program Chairman, Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP [Webcast]This program is intended for interventional cardiologists, as well as physician specialists who manage patients in the emergency department, coronary care unit, and cardiac catheterization laboratory. The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)TM.

• Innovations in Beta-Blocker Therapy for Hypertension: Nitric Oxide, Hemodynamic Profiles, and Effects on Vascular Endothelium—Program Faculty: William H. Frishman, MD [Webcast]This program is designed for all practitioners with the following specialties or subspecialties: Primary Care, Cardiologists, Hypertension Specialists, Internists with Cardiology Specialty Focus, Preventive Medicine Specialists, and Endocrinologists. The University of Massachusetts Medical School designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM.